ShockWave Medical Statistics
Total Valuation
WSTRF has a market cap or net worth of 36.91 million. The enterprise value is 34.02 million.
| Market Cap | 36.91M |
| Enterprise Value | 34.02M |
Important Dates
The next estimated earnings date is Tuesday, August 12, 2025.
| Earnings Date | Aug 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 65.30M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +22.65% |
| Shares Change (QoQ) | +3.60% |
| Owned by Insiders (%) | n/a |
| Owned by Institutions (%) | n/a |
| Float | 56.86M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 216.16 |
| PB Ratio | 1.34 |
| P/TBV Ratio | 2.06 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -3.31 |
| EV / Sales | 191.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -2.86 |
Financial Position
The company has a current ratio of 4.72
| Current Ratio | 4.72 |
| Quick Ratio | 4.03 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -33.84% and return on invested capital (ROIC) is -21.57%.
| Return on Equity (ROE) | -33.84% |
| Return on Assets (ROA) | -19.02% |
| Return on Invested Capital (ROIC) | -21.57% |
| Return on Capital Employed (ROCE) | -34.01% |
| Revenue Per Employee | 5,336 |
| Profits Per Employee | -321,024 |
| Employee Count | 32 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -56.10% in the last 52 weeks. The beta is 2.00, so WSTRF's price volatility has been higher than the market average.
| Beta (5Y) | 2.00 |
| 52-Week Price Change | -56.10% |
| 50-Day Moving Average | 0.66 |
| 200-Day Moving Average | 0.77 |
| Relative Strength Index (RSI) | 37.37 |
| Average Volume (20 Days) | 109,360 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, WSTRF had revenue of 170,751 and -10.27 million in losses. Loss per share was -0.18.
| Revenue | 170,751 |
| Gross Profit | -5.50M |
| Operating Income | -10.48M |
| Pretax Income | -10.27M |
| Net Income | -10.27M |
| EBITDA | -9.77M |
| EBIT | -10.48M |
| Loss Per Share | -0.18 |
Balance Sheet
The company has 2.77 million in cash and n/a in debt, giving a net cash position of 2.77 million.
| Cash & Cash Equivalents | 2.77M |
| Total Debt | n/a |
| Net Cash | 2.77M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 27.44M |
| Book Value Per Share | 0.46 |
| Working Capital | 2.55M |
Cash Flow
In the last 12 months, operating cash flow was -8.73 million and capital expenditures -3.16 million, giving a free cash flow of -11.88 million.
| Operating Cash Flow | -8.73M |
| Capital Expenditures | -3.16M |
| Free Cash Flow | -11.88M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -6,135.59% |
| Pretax Margin | -6,016.22% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
WSTRF does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -22.65% |
| Shareholder Yield | n/a |
| Earnings Yield | -27.83% |
| FCF Yield | -32.20% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
WSTRF has an Altman Z-Score of 7.09 and a Piotroski F-Score of 1.
| Altman Z-Score | 7.09 |
| Piotroski F-Score | 1 |